{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:14Z","timestamp":1792597094277,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cll.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:13:26Z","timestamp":1786493606000},"page":"685-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Drug Monitoring Considerations in Pregnancy"],"prefix":"10.1016","volume":"46","author":[{"given":"Matthew D.","family":"Krasowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2026.07.001_bib1","series-title":"Clinical challenges in therapeutic drug monitoring: special populations, physiological conditions, and pharmacogenomics. Amstersdam","year":"2016"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"51.e1-8","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/FTD.0000000000000709","article-title":"Therapeutic drug monitoring in pregnant patients","volume":"42","author":"Johnson-Davis","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FTD.0000000000001039","article-title":"Optimizing therapeutic drug monitoring in pregnant women: a critical literature review","volume":"45","author":"Moreira","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/cid\/ciz121","article-title":"Importance of prospective studies in pregnant and breastfeeding women living with human immunodeficiency virus","volume":"69","author":"Colbers","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.2048","article-title":"Optimizing pharmacology studies in pregnant and lactating women using lessons from HIV: a consensus statement","volume":"110","author":"Eke","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib7","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.cll.2026.07.001_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/252676","article-title":"Review of NVP and HG and early pharmacotherapeutic intervention","volume":"2012","author":"Clark","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s005350170056","article-title":"Gastric emptying and orocecal transit time in pregnancy","volume":"36","author":"Chiloiro","year":"2001","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00007691-200202000-00003","article-title":"Clinical relevance of therapeutic drug monitoring during pregnancy","volume":"24","author":"Loebstein","year":"2002","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"4 Pt 2","key":"10.1016\/j.cll.2026.07.001_bib12","first-page":"H1060","article-title":"Serial study of factors influencing changes in cardiac output during human pregnancy","volume":"256","author":"Robson","year":"1989","journal-title":"Am J Physiol"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-0528.1974.tb00522.x","article-title":"Glomerular filtration during and after pregnancy","volume":"81","author":"Davison","year":"1974","journal-title":"J Obstet Gynaecol Br Commonw"},{"issue":"10","key":"10.1016\/j.cll.2026.07.001_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cll.2026.07.001_bib15","series-title":"Clinical challenges in therapeutic drug monitoring: special populations, physiological conditions, and pharmacogenomics","article-title":"Therapeutic drug monitoring in pregnancy","author":"Campbell","year":"2016"},{"issue":"6","key":"10.1016\/j.cll.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1985.114","article-title":"Pregnancy-induced increase in metoprolol metabolism","volume":"37","author":"Hogstedt","year":"1985","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.112.050245","article-title":"Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?","volume":"41","author":"Isoherranen","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.dmpk.2015.05.002","article-title":"Polymorphisms of ABCG2, ABCB1 and HNF4alpha are associated with lamotrigine trough concentrations in epilepsy patients","volume":"30","author":"Zhou","year":"2015","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"10","key":"10.1016\/j.cll.2026.07.001_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae585","article-title":"Ideal time to conduct a pharmacokinetic investigation after delivery to fully capture the effect of pregnancy on drug exposure","volume":"11","author":"Berton","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"issue":"13","key":"10.1016\/j.cll.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","article-title":"Complications during pregnancy in women with epilepsy: population-based cohort study","volume":"116","author":"Borthen","year":"2009","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.1998.tb01186.x","article-title":"Pregnancies of women with epilepsy: a population-based study in Iceland","volume":"39","author":"Olafsson","year":"1998","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(25)00130-9","article-title":"Management of reproductive risks in people with epilepsy","volume":"24","author":"Bjork","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cll.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cca.2014.06.002","article-title":"Advances in anti-epileptic drug testing","volume":"436","author":"Krasowski","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"10.1016\/j.cll.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.cll.2026.07.001_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.seizure.2021.10.015","article-title":"Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP)","volume":"93","author":"Thomas","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.291.5.615","article-title":"The new antiepileptic drugs: clinical applications","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cll.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1315","article-title":"Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy","volume":"9","author":"Ding","year":"2019","journal-title":"Brain Behav"},{"issue":"6","key":"10.1016\/j.cll.2026.07.001_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","article-title":"Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service","volume":"46","author":"Morris","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cll.2026.07.001_bib34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.toxrep.2021.08.005","article-title":"Correlation of elevated lamotrigine and levetiracetam serum\/plasma levels with toxicity: a long-term retrospective review at an academic medical center","volume":"8","author":"Wood","year":"2021","journal-title":"Toxicol Rep"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib36","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1528-1167.2006.00819.x","article-title":"In situ metabolism of levetiracetam in blood of patients with epilepsy","volume":"47","author":"Patsalos","year":"2006","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"issue":"1\u201302","key":"10.1016\/j.cll.2026.07.001_bib38","first-page":"e1","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1016\/j.cll.2026.07.001_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/00003088-200342120-00002","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1528-1167.2006.00459.x","article-title":"Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium","volume":"47","author":"Mazzucchelli","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.cll.2026.07.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110658","article-title":"Women with epilepsy during pregnancy: a systematic review of current guidelines","volume":"171","author":"Liu","year":"2025","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/bfm.2020.0210","article-title":"Evaluation of the safety of taking lamotrigine during lactation period","volume":"16","author":"Yashima","year":"2021","journal-title":"Breastfeed Med"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40263-025-01202-7","article-title":"Management of bipolar disorder in pregnancy and postpartum: a clinicians\u2019 guide","volume":"39","author":"Bergink","year":"2025","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"Deligiannidis","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/schbul\/sbn107","article-title":"Antipsychotic therapy during early and late pregnancy. A systematic review","volume":"36","author":"Gentile","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.cll.2026.07.001_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2019.12.014","article-title":"The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability","volume":"264","author":"Molenaar","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cpt.770","article-title":"Treatment with antipsychotics in pregnancy: changes in drug disposition","volume":"103","author":"Westin","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"11\u201312","key":"10.1016\/j.cll.2026.07.001_bib48","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17425255.2025.2593995","article-title":"Psychotropic drugs in pregnancy and lactation","volume":"21","author":"Marazziti","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1441","article-title":"Trend of antidepressants before, during, and after pregnancy across two decades-A population-based study","volume":"9","author":"Sun","year":"2019","journal-title":"Brain Behav"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169907","article-title":"The impact of antenatal depression on perinatal outcomes in Australian women","volume":"12","author":"Eastwood","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib51","article-title":"Untreated depression during pregnancy and its effect on pregnancy outcomes: a systematic review","volume":"13","author":"Jahan","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-020-00996-6","article-title":"Perinatal mood and anxiety disorders, serious mental illness, and delivery-related health outcomes, United States, 2006-2015","volume":"20","author":"McKee","year":"2020","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","article-title":"Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births","volume":"16","author":"Gao","year":"2018","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib54","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0004867413492219","article-title":"Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations","volume":"47","author":"Myles","year":"2013","journal-title":"Aust N Z J Psychiatr"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/2008-2231-20-75","article-title":"Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: a systematic review and updated meta-analysis","volume":"20","author":"Nikfar","year":"2012","journal-title":"Daru"},{"key":"10.1016\/j.cll.2026.07.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110228","article-title":"Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: a systematic review & combined analysis","volume":"107","author":"Schoretsanitis","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41540-020-00157-3","article-title":"Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy","volume":"6","author":"George","year":"2020","journal-title":"npj Syst Biol Appl"},{"issue":"9956","key":"10.1016\/j.cll.2026.07.001_bib58","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(14)61278-2","article-title":"Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period","volume":"384","author":"Jones","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib59","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21r14045","article-title":"Prevalence of bipolar disorder in perinatal women: a systematic review and meta-analysis","volume":"83","author":"Masters","year":"2022","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/neurolint14010005","article-title":"Antipsychotic use in pregnancy: patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"key":"10.1016\/j.cll.2026.07.001_bib61","article-title":"Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study","volume":"10","author":"Fabre","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/1471-0528.12073","article-title":"Are prenatal, obstetric, and infant complications associated with postpartum psychosis among women with pre-conception psychiatric hospitalisations?","volume":"120","author":"Hellerstedt","year":"2013","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib63","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/schbul\/sbs109","article-title":"Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder","volume":"39","author":"Suvisaari","year":"2013","journal-title":"Schizophr Bull"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40262-020-00962-3","article-title":"Dose adjustment of quetiapine and aripiprazole for pregnant women using physiologically based pharmacokinetic modeling and simulation","volume":"60","author":"Zheng","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib65","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jphp.13236","article-title":"Quetiapine dose optimisation during gestation: a pharmacokinetic modelling study","volume":"72","author":"Badhan","year":"2020","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2026.07.001_bib66","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1046\/j.1365-2125.2000.00151.x","article-title":"Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions","volume":"49","author":"Prakash","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib67","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/138920008784746373","article-title":"Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions","volume":"9","author":"Urichuk","year":"2008","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0033-1347176","article-title":"Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties","volume":"46","author":"Holthoewer","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00737-022-01234-8","article-title":"Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study","volume":"25","author":"Sague-Vilavella","year":"2022","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40345-023-00317-4","article-title":"High lithium concentration at delivery is a potential risk factor for adverse outcomes in breastfed infants: a retrospective cohort study","volume":"11","author":"Whaites Heinonen","year":"2023","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.cll.2026.07.001_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.752022","article-title":"Neonatal feeding trajectories in mothers with bipolar disorder taking lithium: pharmacokinetic data","volume":"12","author":"Imaz","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/JCP.0000000000001740","article-title":"Prophylactic management of women with bipolar disorder during pregnancy and the perinatal period: clinical scenario-based practical recommendations from a group of perinatal psychiatry authors","volume":"43","author":"Uguz","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13318-017-0421-2","article-title":"Population pharmacokinetic analyses of lithium: a systematic review","volume":"43","author":"Methaneethorn","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015738","article-title":"Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway","volume":"7","author":"Westin","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ogc.2020.11.006","article-title":"Psychiatric medication use in pregnancy and breastfeeding","volume":"48","author":"Payne","year":"2021","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-016-0670-0","article-title":"A review of the safety of clozapine during pregnancy and lactation","volume":"20","author":"Mehta","year":"2017","journal-title":"Arch Womens Ment Health"},{"issue":"11","key":"10.1016\/j.cll.2026.07.001_bib77","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/j.1875-9114.1982.tb03187.x","article-title":"A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy","volume":"2","author":"Fitzpatrick","year":"1982","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.cll.2026.07.001_bib79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2174\/1389200217666160629114449","article-title":"The role of drug transporters in the pharmacokinetics of antibiotics","volume":"17","author":"Hua","year":"2016","journal-title":"Curr Drug Metab"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib80","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/dmd.112.049569","article-title":"Organic anion transporter 3 interacts selectively with lipophilic beta-lactam antibiotics","volume":"41","author":"Wolman","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.cll.2026.07.001_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2125.2008.03220.x","article-title":"Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women","volume":"66","author":"Roustit","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FTD.0b013e318261c372","article-title":"Therapeutic drug monitoring in pregnancy","volume":"34","author":"Matsui","year":"2012","journal-title":"Ther Drug Monit"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/0956462416656705","article-title":"Retrospective analysis of the associations and effectiveness of performing therapeutic drug monitoring in pregnant HIV-positive women in two large centres in Manchester","volume":"28","author":"Whitfield","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"issue":"7","key":"10.1016\/j.cll.2026.07.001_bib85","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2018.11.055","article-title":"Outcomes of pregnancy in recipients of liver transplants","volume":"17","author":"Kamarajah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cll.2026.07.001_bib86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/FTD.0b013e3182708edf","article-title":"Pharmacokinetics of tacrolimus during pregnancy","volume":"34","author":"Zheng","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.001_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.621247","article-title":"Biologics during pregnancy and breastfeeding among women with rheumatic diseases: safety clinical evidence on the road","volume":"12","author":"Beltagy","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cll.2026.07.001_bib88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cll.2026.07.001_bib89","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdz228","article-title":"Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting","volume":"30","author":"Amant","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.cll.2026.07.001_bib90","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/annonc\/mdu376","article-title":"Drug selection and dosing in pregnant cancer patients: insights from clinical pharmacokinetics","volume":"25","author":"Berveiller","year":"2014","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/CCO.0000000000000386","article-title":"Cancer in pregnancy: safety and efficacy of systemic therapies","volume":"29","author":"Boere","year":"2017","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO-25-02115","article-title":"Management of cancer during pregnancy: ASCO guideline","volume":"44","author":"Loren","year":"2026","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2020.151226","article-title":"Task force on research specific to pregnant and lactating women","volume":"44","author":"Byrne","year":"2020","journal-title":"Semin Perinatol"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2026.07.001_bib98","first-page":"S18","article-title":"The importance of clinical research in pregnant women to inform prescription drug labeling","volume":"60","author":"Dinatale","year":"2020","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.cll.2026.07.001_bib99","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/cpt.2212","article-title":"Assuring access to safe medicines in pregnancy and breastfeeding","volume":"110","author":"Nooney","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cll.2026.07.001_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02168-20","article-title":"Population pharmacokinetics of tenofovir in pregnant and postpartum women using tenofovir disoproxil fumarate","volume":"65","author":"Eke","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cll.2026.07.001_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461731","article-title":"A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring","volume":"1635","author":"Tey","year":"2021","journal-title":"J Chromatogr A"},{"issue":"5","key":"10.1016\/j.cll.2026.07.001_bib102","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jalm\/jfae075","article-title":"Remote blood collection devices improve study participation from hard to reach populations","volume":"9","author":"Krasowski","year":"2024","journal-title":"J Appl Lab Med"},{"issue":"2\u20133","key":"10.1016\/j.cll.2026.07.001_bib103","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2009.08.004","article-title":"Pharmacokinetics of topiramate during pregnancy","volume":"87","author":"Ohman","year":"2009","journal-title":"Epilepsy Res"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:40:14Z","timestamp":1792593614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0272271226000715"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.001","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Drug Monitoring Considerations in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}